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Background: Sleep-Disordered Breathing (SDB) varies from habitual snoring to partial
or complete obstruction of the upper airway and can be found in up to 10% of
children. SDB can significantly affect children’s wellbeing, as it can cause growth
disorders, educational and behavioral problems, and even life-threatening conditions,
such as cardiorespiratory failure. Adenotonsillectomy represents the primary treatment
for pediatric SDB where adeno-tonsillar hypertrophy is indicated. For those with
craniofacial anomalies, or for whom adenotonsillectomy or other treatment modalities
have failed, or surgery is contra-indicated, mandibular advancement splints (MAS) may
represent a viable treatment option. Whilst the efficacy of these appliances has been
consistently demonstrated in adults, there is little information about their effectiveness in
children.
Aims: To determine the efficacy of mandibular advancement appliances for the
management of SDB and related health problems in children.
Methods/design: The study will be designed as a single-blind crossover randomized
controlled trial with administration of both an “Active MAS” (Twin-block) and a “Sham
MAS.” Eligible participants will be children aged 8–12 years whose parents report they
snore ≥3 nights per week. Sixteen children will enter the full study after confirming other
inclusion criteria, particularly Skeletal class I or class II confirmed by lateral cephalometric
radiograph. Each child will be randomly assigned to either a treatment sequence
starting with the Active or the Sham MAS. Participants will wear the appliances for
3 weeks separated by a 2-week washout period. For each participant, home-based
polysomnographic data will be collected four times; once before and once after each
treatment period. The Apnea Hypopnea Index (AHI) will represent the main outcome
variable. Secondary outcomes will include, snoring frequency, masseter muscle activity,
sleep symptoms, quality of life, daytime sleepiness, children behavior, and nocturnal
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enuresis. In addition, blood samples will be collected to assess growth hormone
changes.
Trial registration: This study was registered in the Australian New Zealand Clinical Trials
Registry (ANZCTR): [ACTRN12614001013651].
Keywords: behavior, growth hormone, mandibular advancement appliance, quality of life, sleep apnea, sleep
disordered breathing, snoring
INTRODUCTION
The health impact of sleep-disordered breathing (SDB),
particularly, obstructive sleep apnea (OSA) has been increasingly
recognized in both adults and children (Marcus, 2001; Casale
et al., 2009). The prevalence of OSA in children varies from 1 to
4% (Rosen et al., 2003; Bixler et al., 2009; Bonuck et al., 2011),
whilemost authors report a 10% prevalence of habitual snoring in
children (Lumeng and Chervin, 2008). SDB has been associated
with growth disorders (Marcus et al., 1994), daytime sleepiness
(Li and Lee, 2009), educational and behavioral problems
(Blunden et al., 2000; Galland et al., 2015), and nocturnal
enuresis (Stone et al., 2008). In the most severe cases, OSA may
have life-threatening consequences like cardiorespiratory failure,
which can lead to death (Ross et al., 1987; Lavie, 2004).
Enlarged adenoids and tonsils are the most common etiology
of OSA in children. Obesity during childhood represents another
important risk factor for OSA (Horner et al., 1989; Gozal
and Kheirandish-Gozal, 2009). Craniofacial anomalies are also
associated with changes in airway morphology and respiratory
problems (McNamara, 1981). These anomalies, basically, include
maxillary and mandibular retrognathia, increased facial height,
decreased facial width, increased overjet, and palatal crossbite
(Lofstrand-Tidestrom et al., 1999; Cakirer et al., 2001; Kawashima
et al., 2002; Li et al., 2002; Ozdemir et al., 2004; Juliano et al., 2009;
Pirila-Parkkinen et al., 2009; Flores-Mir et al., 2013; Katyal et al.,
2013).
Polysomnography (PSG) is considered the gold standard for
SDB diagnosis (Casale et al., 2009), and the apnea hypopnea
index (AHI) is the main outcome to aid diagnosis. AHI is defined
as the number of apnea and hypopnea events recorded per hour
of sleep. A pediatric OSA event, relying on PSG, is defined as
absence of airflow for two respiratory cycles (2 breaths) with
continued chest wall and abdominal wall movement (Berry et al.,
2012). Whereas, obstructive hypopnea is defined as a decrease in
nasal flow ≥30% (lasting at least 2 breaths) with a corresponding
decrease in oxygen saturation ≥3% and/or arousal (Berry et al.,
2012).
Full PSG is costly to perform in sleep laboratory, and
scoring sleep stages is time consuming (Collop et al., 2007).
Consequently, over the last decades, there has been increased
interest in cost-effective methods of diagnosing SDB within the
home setting using portable monitoring devices (Bridevaux et al.,
2007; Polese et al., 2010). Type III home PSG, also referred
to as abbreviated PSG without electonecephalogram (EEG),
electrooculogram (EOG), and electromyogram (EMG), has been
used in the majority of the published studies on home testing of
SDB in children; this abbreviated PSG, is more suitable for use in
children, it is less time-consuming, and it is easier to set up and
score (Tan et al., 2015).
The first line and the most common treatment for pediatric
OSA is adenotonsillectomy (Li and Lee, 2009; Marcus et al.,
2012). Although significant improvements in the AHI are
observed following adenotonsillectomy, full resolution of OSA
(AHI ≤ 1) occurs only in 27–60% of cases (Friedman et al.,
2009; Bhattacharjee et al., 2010). Adenotonsillectomy is also
associated with risk of postoperative complications beyond the
anesthetic and surgical procedures. For example, OSA children
show a significantly higher risk of respiratory compromise,
defined as intermittent or continuous oxygen saturation of 70%
or less, and/or hypercapnia, requiring intervention after surgery
(McColley et al., 1992; Gross et al., 2006). Children with obesity,
severe OSA, or craniofacial abnormalities may require more
protracted inpatient care and/or intensive care unit observation
(Leong and Davis, 2007; Isaacson, 2014). Studies have reported
an accelerated mandibular ramus growth and improved facial
morphology after adenotonsillectomy in pediatric OSA patients
(Agren et al., 1998). This improvement may be due to
normalization in growth hormone (GH) serum levels, also to
a change of tongue and cheek posture (Woodside et al., 1991).
However, this growth acceleration is not sufficient to correct
the malocclusion and the underlying skeletal discrepancy often
requires subsequent dentofacial growth modification treatment
(Peltomäki, 2007).
Continuous positive air pressure (CPAP) is the primary
treatment option for adult OSA (Casale et al., 2009). CPAP is
also advocated for severe pediatric SDB (Agren et al., 1998), or
for persistent OSA after adenotonsillectomy, but it is generally
not well tolerated by children (Marcus et al., 2012). Adherence
to CPAP treatment in children is a major problem, with rates
of only 30–70% (O’Donnell et al., 2006; Uong et al., 2007).
From a biomechanical stand-point, there are anecdotal reports of
potential facial growth disturbances from long-term use of CPAP
due to the elastic strap which maintains the mask, as it may apply
a restraining force on the growing maxilla (Conley, 2011).
Oral appliances have also been widely used for the treatment
of OSA, particularly in adults (Villa et al., 2002; Ferguson et al.,
2006; Casale et al., 2009). These appliances increase the posterior
oropharyngeal airway and reduce upper airway collapsibility
by holding the mandible in a protruded position during sleep;
furthermore, the device may trigger stretch receptors, which
in turn activate the airway supporting muscles (Casale et al.,
2009). Previous studies have shown that oral appliances are better
tolerated than CPAP treatment (Ferguson et al., 2006) because
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of improved comfort, quietness, and portability. Mandibular
advancement appliances are the most common type of oral
appliances used in the treatment of SDB in adults, but their
use in children is less common, with little information about
their efficacy (Ferguson et al., 2006). The few studies on the
subject suffer from important methodological flaws, making it
difficult to reach a definitive conclusion about the efficacy ofMAS
appliances in children with SDB (Villa et al., 2002; Cozza et al.,
2004; Carvalho et al., 2007; Huynh et al., 2015; Nazarali et al.,
2015).
OBJECTIVES
Aims of the study are:(1) to test the short-term efficacy of MAS
in the treatment of children with SDB; and (2) to assess the effect
of MAS treatment on quality of life, behavior, growth hormone
levels, and nocturnal enuresis in SDB children.
MATERIALS AND METHODS
Study Design
This study will be carried out as a single-blind crossover
randomized controlled trial. Each participant will wear two
appliances consisting of an active MAS and non-active MAS
(ShamMAS). Each appliance will be worn for a 3-week treatment
period, which will be separated by a 2-week washout period.
A similar study design and treatment time have been used in
previous studies comparing the efficacy of MAS to nasal CPAP
treatment in adults (Ferguson et al., 1996, 1997).
This study will be conducted in the Discipline of
Orthodontics, School of Dentistry University of Otago, New
Zealand. Ethical approval has been granted by the Human Ethics
Committee at University of Otago [H14/054], and New Zealand
Health Research South Ethics Committee- Southern District
Health Board [01050]. The research has also been approved
by Nga¯i Tahu Research Consultation Committee (Research
consultation with Ma¯ori).
Participants
Sample Size Estimation
A reduction of 50% in AHI is generally considered clinically
relevant (Ferguson et al., 2006). This change corresponds to a
large effect size (Cohen’s d = 1.5). To detect this effect size, and
setting α error to 0.05 and β error to 0.20 (one-tail test) using a
repeated-measurement design, we have estimated that at least 13
participants are needed. We will recruit 16 children to account
for possible dropouts.
Recruitment
We will advertise in local newspapers to invite children who
live in Dunedin city/New Zealand, to participate in the study
according to the following eligibility criteria: age 8–12 years;
parental report of snoring three nights or more per week.
Eligible patients should meet the following selection criteria:
A score for the Pediatric Sleep Questionnaire (PSQ) ≥0.33
(Chervin et al., 2000); class II or class I incisor relationships;
Skeletal maxillomandibular relations of class I or class II which
will be confirmed by lateral cephalometric radiograph (ANB
angle and Wit’s appraisal; Steiner, 1959; Jacobson, 1975).
Exclusion criteria include severe OSA defined as an AHI >10
(Association ASA, 2013); craniofacial syndromes and genetic
syndromes; neuromuscular diseases; or Angle class III incisor
relationships; previous orthodontic treatment.
Patients diagnosed with severe OSA will be referred to a
Medical Specialist.
Oral Appliances
An n-of-1 pilot study was undertaken to compare the acceptance,
and the mechanical retention of different splint designs to choose
the best design to be used in themain study. Four appliances were
identified and tested in an 11-year old boy with class II dental and
skeletal jaw relationships, the appliances were: Traditional Twin-
block (Clark, 1988); Twin-block with metallic fastener (TAP R©-
splint, SCHEU Dental Technology, Brussels, Belgium); Clear
elastic Twin-block; Sham Twin-block (Figure 1).
As discomfort affects adaptation and acceptance (Sergl and
Zentner, 1998; Idris et al., 2012), this was evaluated in a pilot
study using two assessment methods: the participant was firstly
asked to report how comfortable was each appliance immediately
after insertion into the oral cavity in compare to the other
appliances. The four appliances were presented in pairs to
compare each appliance to the remaining three (a total of 12
pairs were generated to avoid confounding caused by sequence of
appliances application); the participant was instructed to insert
an appliance into the mouth and he was asked to move the
mandible to the right and left, front and back, and then to
swallow, then to repeat the same to another appliance; after
that the participant was asked to indicate which of the two
appliances was more comfortable to wear. The second method
aimed to assess acceptance after wearing the appliance for 2 h
while awake and during one night sleep. One night appliance-
free was allowed as washout period between two sequentially-
tested appliances. Discomfort was assessed by using a 100-mm
FIGURE 1 | Appliances tested in a pilot study to identify the most
suitable appliance design to be used in the main study. (A) Traditional
Twin-block: Removable upper and lower acrylic plates, each plate has
matching pieces to encourage the lower jaw to slide forward, bilateral hooks
were added to insert vertical elastics. (B) Metallic fastener Twin-block:
Removable upper and lower vacuum formed plates and a metallic fastener
(TAP) is used to hook the upper and the lower plates enabling the mandible to
be advanced forward. (C) Clear elastic Twin-block: Removable upper and
lower vacuum formed plates with matching pieces to encourage the lower jaw
to slide forward, bilateral plastic hooks were added to accommodate vertical
elastics. (D) Sham Twin-block: Removable upper and lower vacuum formed
plates, without any lower jaw advancing device.
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visual analog scale (VAS) with words (worse than I can imagine;
better than I can imagine) anchored at the left and right end of
the scale, corresponding to worse discomfort and best comfort,
respectively. The participant rated the discomfort intensity by
putting a vertical slash on the line that best represented the
intensity of discomfort. The higher the VAS score the better the
appliance acceptance. Two separate VAS scores were collected
after both the awake and asleep wearing periods.
Retention was tested using both a subjective and an objective
assessment. Subjective assessment was made by asking the
participant (1) if the appliance was held in the mouth the whole
night, (2) if the upper and lower splints were fitting well to the
teeth, and (3) if the upper and lower splints stay attached to each
other. Response options were yes/no.
Passive and active retention were also objectively tested by
two independent examiners (GI, MF) by checking whether the
appliance was stable in-mouth upon, (1) maximum jaw opening
and, (2) direct pulling of the examiner.
Since the traditional Twin-block appliance showed the best
retention and acceptance this was chosen as the study protocol
intervention. Additional arguments in support of this decision
were:
• It is easy to titrate and can also be used to expand the upper
arch.
• It includes metal clasps to increase retention as required.
• It is very popular amongst orthodontists and has been
extensively tested in previous research.
• It has a low failure rate and is well tolerated by children (Morris
et al., 1998).
• It can be used for facial growth modification in patients with
skeletal class II jaw relationship.
Twin-Block Design (Active MAS)
This consists of two removable upper and lower plates; each
plate has matching pieces which encourage the lower jaw to
posture or slide forward as the teeth come together (Figure 2)
(Clark, 1988). Hooks will be added to the Twin-block bilaterally
to insert vertical elastics. These elastics will hold themouth closed
during sleep and the mandible postured in a forward position
(Barnes et al., 2004). The construction bite of the appliance
will be determined using the George GaugeTM (George, 1992),
FIGURE 2 | Appliances to be used in the study. (A) Twin-block appliance
(active MAS). (B) Sham MAS (non-active MAS).
which allows an accurate determination and registration of the
mandibular advancement. The bite registration will be taken for
all participants by advancing the mandible 75% of the maximum
protruded position of the jaw with minimum bite opening.
Sham MAS Design (Non-active MAS)
This consists of two non-active upper and lower acrylic plates
resembling the design of the active MAS, but without any
component to protrude the mandible (Figure 2).
Randomization
Participants will be randomly assigned to either a sequence
starting with the Twin-block or the Sham MAS. Thereafter,
participants will wear the appliances for 3 weeks separated by a 2-
week washout period. Participants will not be told whether they
wear the active or the non-active appliance. Each night of wear
time will be recorded by parents using diaries.
Patients will be allocated to active or sham treatment using
four randomized n-of-4 blocks that are balanced for treatment
sequence (Sequence 1: Twin-block MAS first followed by Sham
MAS; sequence 2: ShamMAS first followed by Twin-block MAS;
Figure 3). Allocation will be concealed in opaque envelopes, and
disclosed by a member of the research team (MF) immediately
after enrolment. Participant flow is illustrated in (Figure 3).
OUTCOME MEASUREMENTS AND
STEPWISE PROCEDURE
Sleep Data
Home-based abbreviated polysomnography, Type III (Polese
et al., 2010), will be performed using a portable monitoring unit
(Embletta MRP PG-XS-ENU, Natus Neurology Incorporated,
Ontario, Canada).
PSG recording channels in the Embletta unit will be
comprised of one electromyographic (EMG) channel, a finger
pulse oximetry, nasal airflow (using a nasal pressure catheter),
nasal and mouth thermistry, thoracic and abdominal respiratory
effort bands (two piezoelectric belts will be placed around the
rib cage and abdomen and monitor respiratory movement),
body position sensors, and a microphone attached to the nasal
cannula extension. The following variables will be measured:
pulse oximetry, airflow, respiratory effort, snoring sound, body
position, and EMG of the masseter muscle. This equipment has
previously been validated for the diagnosis and management of
SDB (Dingli et al., 2003; Skomro et al., 2010; Fredheim et al., 2014;
Park do et al., 2015).
The portable device is set up through the use of a separate
application software, RemLogic-E version 3.4 (Embla system,
Natus Europe, Planegg, Germany). Channels are configured and
identified, sampling rates set, filtering options defined, recording
timing (on/off times), etc. through the same software.
Home-based PSG data will be collected four times for each
participant at baseline and after treatment with Twin-block or
ShamMAS, with the support of a research assistant (Figure 4).
The AHI will be calculated according to the American
Academy of SleepMedicine (AASM) criteria for scoring pediatric
respiratory sleep studies (Berry et al., 2012). AHI is the main
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FIGURE 3 | Participants’ flow in the study.
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FIGURE 4 | The study design is a crossover randomized controlled trial. Sixteen patients will be randomly assigned to two sequences; both sequences include
a 3-week treatment period with active and non-active (sham) mandibular advancement splints but in a different order (Active followed by Non-active and Non-active
followed by Active). Treatment periods will be separated by a 2-week washout period. Assessments will be taken at baseline (T0) and four times throughout the study.
PSF, polysomnography; Ceph, Cephalograms; PSQ, Pediatric Sleep Questionnaire; BASC-2, Behavior Assessment System for Children, second edition; OSA-18,
Quality of Life questionnaire; ESS, Epworth Sleepiness Scale (ESS).
outcome of interest and sleep position will be considered in
AHI scoring because sleep related obstructive respiratory events
in children occur more commonly in the supine sleep position
(El-Kersh et al., 2016).
Snoring Frequency
Snoring sounds will be assessed by analyzing audio recordings
recorded using the portable PSG equipment. Snoring will be
scored manually by listening to the audio recording using
RemLogic-E software and the result will be reported as: total
snoring time, relative snoring time, number of snoring episodes,
average snoring episodes, and longest snoring episode.
The use of audio recordings is one of the recommended
methods to aid visualize snoring oscillations (Berry et al.,
2012). Embletta MPR microphone (an analog omnidirectional
condenser microphone) attached to nasal cannula will record
the snoring sounds. All signals will be fed into analog/digital
(A/D) converter with a 200 Hz sampling rate (each channel
has 200 points or samples per second; Shiomi et al., 2011). For
optimal visualization of snoring, a high-pass filter to remove
very low frequencies (20 Hz) and a low-pass filter to remove
high frequencies (3 kHz) will be used, this will permit acquiring
relevant information of snoring sounds (Pevernagie et al., 2010).
Subjective reports of snoring frequency will also be collected
by parents using daily diaries throughout each treatment period
(Figure 4).
Growth Hormone Levels
Blood samples will be taken from all participants by a certified
phlebotomist in a medical laboratory (Southern Community
Laboratories). Growth hormone will be indirectly assessed by
determination of insulin-like growth factor-1 (IGF-1) levels
(Laron, 2001).
Two samples will be collected at the end of each treatment
period and collected in a non-fasting state in the morning
to early afternoon. IGF-1 concentrations were assayed using a
human IGF-I quantikine ELISA Kit (PDG100, R&D Systems,
Minneapolis, USA). The human IGF-1 immunoassay employs
the quantitative sandwich enzyme technique. Samples will be
stored in a −80◦C freezer until batch assayed by a technician
who will be blinded to the treatment period. Disposal of medical
wastes will follow the World Health Organization guidelines
(WHO, 2007, 2016), and disposal with appropriate karakia
(Ma¯ori prayer) will be offered to participant if needed.
SDB and Daytime Sleepiness
Questionnaires
SDB associated symptoms will be assessed using the Pediatric
Sleep Questionnaire and Sleep Related Breathing Disorder
(SRBD) subscale (PSQ-SRBD; Chervin et al., 2000). This 22-
question tool will be filled in by parents and includes questions
about history of breathing difficulties during sleep, snoring
quality and frequency, daytime signs of sleepiness, Inattention
and hyperactivity, in addition to few other questions about
morning headache, obesity, enuresis, and delayed growth. The
optimal SRBD scale cut-off to indicate presence of SDB would
be 0.33 (i.e., ≥33% of the 22 question-items answered positively;
Chervin et al., 2000).
Daytime sleepiness and related behavioral disturbances will be
assessed using the Epworth Sleepiness Scale (ESS; Manni et al.,
1999). ESS is a self-administered questionnaire with 8 questions;
it provides a measure of a person’s general level of daytime
sleepiness, or their average sleep propensity in daily life. It has
become the standard method for making this assessment. The
ESS asks people to rate, on a 4-point scale (0–3), their usual
chances of dozing off or falling asleep in eight different situations
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or activities that most people engage in as part of their daily
lives. The total ESS score is the sum of 8 item-scores and can
range between 0 and 24. The higher the score, the higher the
person’s level of daytime sleepiness (Johns, 1991, 1993; Manni
et al., 1999). To make this questionnaire suitable for children, the
question about alcohol will be removed and the questionnaire
will be completed by parents/caregivers. PSQ-SRBD and ESS
questionnaires will be administered four times during the study
(Figure 4).
Quality of Life
The OSA-18 instrument is a quality-of-life questionnaire
focusing on pediatric sleep disordered breathing. It has been
used as a screening tool for pediatric OSA (Franco et al.,
2000). This questionnaire consists of 18 questions grouped into
five subscales: sleep disturbance, physical symptoms, emotional
distress, daytime function, and caregiver concerns. The 18 survey
items are scored using a 7-point scale, where the parent/caregiver
is asked to report how often during the previous 2–3 weeks their
child has had specific symptoms using the following response
scale: (1) none of the time, (2) hardly any of the time, (3) a
little of the time, (4) some of the time, (5) a good bit of the
time, (6) most of the time, and (7) all of the time. The total
symptom score (TSS) may vary from 18–126 points. A TSS at
or above 60 is considered abnormal and is associated with SDB.
Scores of 60–80 suggest a moderate impact on the disease-specific
quality of life and a score above 80 suggests a large impact
(Franco et al., 2000).
OSA-18 questionnaire will be administered four
times and parents/caregivers will rate the frequency of
symptoms before and at the end of each treatment period
(Figure 4).
Neurobehavioral Assessment
Behavior will be assessed using the Behavior Assessment System
for Children: second edition (BASC-2). The BASC-2 tool has
been widely used in studying behavioral differences in pediatric
SDB patients (Reynolds and Kamphaus, 2004).
Parent Rating Scales (PRS) are used to measure both adaptive
and maladaptive behaviors in the community and home setting.
Parents or caregivers can complete forms at three age levels—
preschool (ages 2–5), child (ages 6–11), and adolescent (ages
12–21). The PRS contains 134–160 items and uses a four-
choice response format. Clinical and adaptive scales include
the following domains: activities of daily living, adaptability,
aggression, anxiety, attention problems, atypicality, conduct
problems, depression, functional communication, hyperactivity,
leadership, social skills, somatization, and withdrawal.
It takes a parent ∼10–20 min to complete this form
and requires approximately a fourth-grade reading level for
completion. Level two questionnaire (ages 6–11) contains 160
items; but the brief questionnaire of this scale consists of 30
items and will be used in our study. This questionnaire will be
administered before and at the end of each treatment period
(Figure 4).
Parent-Report of Nocturnal Enuresis
As about 24% of children with sleep apnea have nocturnal
enuresis (Kovacevic et al., 2013), urine incontinence will be
assessed during the study by parents/caregivers using diaries in
both treatment periods to report frequency of enuresis.
Sleep Study Scoring
A certified sleep technologist will manually score all PSG data
and AHI according to the AASM criteria (Berry et al., 2012). PSG
scoring will be performed using a special software RemLogic-E
version 3.4 (Embla system, Natus Europe, Planegg, Germany).
The scorer will be blinded to the patients’ information and to any
indication of the treatment period and appliance used, moreover
the technologist will have no contact with the participants
through the study progress. To test reliability of scoring PSG data,
ten PSG recordings will be chosen randomly and re-scored by the
same sleep technician to detect intra-rater reliability.
Statistics
Data will be analyzed by SPSS (SPSS, IBM Corp. Version 22.0.
Armonk, NY, USA) to perform descriptive statistics, and a
mixed model analysis, and Bonferroni corrected post-hoc tests as
appropriate. The significance level will be set at P = 0.05.
DISCUSSION AND ANTICIPATED RESULTS
Early treatment of SDB in children is vital to prevent
significant health issues that may develop later. Therefore,
SDB may have a significant impact on the wellbeing of many
children. With a significant number of cases having persistent
OSA after adenotonsillectomy or failure to tolerate CPAP
treatment, it is worth exploring alternative options to the
current advocated treatment modalities. The MAS intervention
may be a valuable and effective alternative for patients who
have known craniofacial risk factors of SDB, are on long
waiting lists for adenotonsillectomy, are not suitable candidates
for adenotonsillectomy, or are not able to tolerate or failed
either first-line treatments, such as adenotonsillectomy or CPAP
(Huynh et al., 2015).
MAS may be particularly suitable for children with SDB,
because it is relatively well tolerated and can easily titrated to
obtain a incremental advancement of the lower jaw (DeVincenzo
and Winn, 1989). MAS can also expand the upper arch (Clark,
1988), is suitable for both mixed and permanent dentitions
(Clark, 1988) and has a low failure rate (Morris et al., 1998).
The therapeutic rationale is that the majority of orthodontic
anomalies (except class III-protruded mandible), benefit from
mandibular advancement capable of enlarging the retrolingual
space and at the same time promotes lingual advancement (Villa
et al., 2002).
Although there is increasing evidence regarding the efficacy of
MAS in adults with SDB, there is a paucity of information about
their efficacy in children (Carvalho et al., 2007; Chen and Lowe,
2013; Huynh et al., 2015; Nazarali et al., 2015). The few studies
carried out to date suffer from methodological flaws including:
heterogeneous samples; lack of randomization; limited power
to detect a clinically relevant effect; and lack of an adequate
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control conditions such as the use of a placebo-like appliance. A
Cochrane review (Carvalho et al., 2007) has concluded that there
is not enough evidence to support the efficacy of oral appliances
and functional orthopedic appliances for the treatment of OSA
in children. This conclusion was also reached by two recent
systematic reviews and a meta-analysis which confirmed that
the current evidence is limited, but suggests possible short-
term effectiveness for treating pediatric OSA (Huynh et al.,
2015; Nazarali et al., 2015). Therefore, it is currently difficult to
draw a conclusion regarding the possible efficacy of mandibular
advancement appliances in children affected with SDB (Villa
et al., 2002; Cozza et al., 2004; Carvalho et al., 2007; Zhang
et al., 2013), and there is a strong need to carry out well-
designed RCTs.
Cross over RCT design has been widely used in studying
efficacy of oral appliances with OSA patients (Chen and Lowe,
2013). Potential advantages of the crossover design that will
be used in current study are its robustness and simplicity
of application. Despite these advantages, the current study
protocol will have some limitations as it depends on short-term
evaluation (3 weeks for each treatment period), and the study
will rely on subjective assessment of several secondary outcomes
by using questionnaires in evaluating these measures by
parents/caregivers. In addition to the possibility of having limited
power regarding the secondary outcomes because the sample size
estimation was assessed only relying on the main outcome (AHI).
However, the study will serve to provide descriptors of these,
useful for planning further research in the field.
Randomized clinical trials represent the gold standard for
the evaluation of therapeutic effectiveness (Mills et al., 2007)
therefore, unlike the previous studies, it is expected the current
study protocol will provide new robust and reliable information
about the possible efficacy of MAS for the management of SDB
in children. The crossover design will allow each participant
to act as his/her own control, thus increasing the power of
the study. This study will also systematically address efficacy
of MAS on other important health outcomes related to SDB,
such as quality of life, neurobehavioral functioning, and growth
hormone changes; outcomes that have not been widely addressed
in previous intervention studies investigating pediatric snoring
or OSA (Huynh et al., 2015)
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